AI in Pharma and Biotech Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Rising Demand for Speedy Drug Development
   3. Market Restraints
      1. Regulatory Challenges
      2. Data Quality and Accessibility
   4. Market Opportunity
      1. Gene Development through AI Progression
   5. Market Trends
      1. Increase In Collaborations and Partnerships
      2. Rise of AI-Powered Healthcare Start-ups
5. MARKET SEGMENTATION
   1. By Application
      1. Drug Discovery and Development
      2. Clinical Trials and Optimization
      3. Predictive Maintenance and Quality Control
      4. Drug Target Identification
      5. Disease Diagnosis and Prognosis
      6. Others
   2. By End-user
      1. Pharmaceutical and Biotech Companies
      2. Academic and Contract Research Organizations
      3. Others (Ambulatory Surgical Centres, etc.)
   3. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Alphabet Inc.
      2. Advanced Micro Devices Inc.
      3. GE Healthcare
      4. InformAI
      5. Koninklijke Philips Inc.
      6. Merative L.P.
      7. Microsoft
      8. Nvidia Corporation
      9. Intel Corporations
      10. Siemens Healthineers
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global AI in Pharma and Biotechmarket?

The global market of AI in Pharma and Biotechis projected to reach USD9.83Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global AI in Pharma and Biotechmarket?

The global AI in Pharma and Biotechmarket has an estimated annual growth rate of 18.5%.

Q.3. What are the recent trends of AI in Pharma and Biotechmarket?

Increasing collaboration and partnerships and rise of AI-powered healthcare start-ups are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in AI in Pharma and Biotech?

The major companies profiled in this report include Atomwise Inc., Berg LLC, Benevolent AI SA, Cloud Pharmaceuticals, Deep Genomics, Exscientia, Insitro, Insilico Medicine, Recursion Pharmaceuticals, Schrödinger, twoXar Inc., among others.  

Q.5. Which is the largest regional market in the AI in Pharma and Biotech?

North America is the largest regional market for AI in Pharma and Biotech.